IN2010KO00035A - - Google Patents
Info
- Publication number
- IN2010KO00035A IN2010KO00035A IN35KO2010A IN2010KO00035A IN 2010KO00035 A IN2010KO00035 A IN 2010KO00035A IN 35KO2010 A IN35KO2010 A IN 35KO2010A IN 2010KO00035 A IN2010KO00035 A IN 2010KO00035A
- Authority
- IN
- India
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/IB2011/050822 WO2011086541A1 (en) | 2010-01-15 | 2011-02-25 | Novel polymorph of nilotinib monohydrochloride monohydrate |
| IN35KO2010 IN2010KO00035A (enExample) | 2010-01-15 | 2011-02-25 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN35KO2010 IN2010KO00035A (enExample) | 2010-01-15 | 2011-02-25 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2010KO00035A true IN2010KO00035A (enExample) | 2016-09-02 |
Family
ID=43828136
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN35KO2010 IN2010KO00035A (enExample) | 2010-01-15 | 2011-02-25 |
Country Status (2)
| Country | Link |
|---|---|
| IN (1) | IN2010KO00035A (enExample) |
| WO (1) | WO2011086541A1 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012070062A2 (en) * | 2010-11-26 | 2012-05-31 | Hetero Research Foundation | Novel polymorph of nilotinib hydrochloride |
| US9061028B2 (en) * | 2012-02-15 | 2015-06-23 | Natco Pharma Limited | Process for the preparation of Nilotinib |
| WO2014059518A1 (en) * | 2012-10-15 | 2014-04-24 | Apotex Technologies Inc. | Solid forms of nilotinib hydrochloride |
| KR20150068483A (ko) | 2012-10-19 | 2015-06-19 | 바스프 에스이 | 닐로티닙 및 선택된 공-결정 형성제를 포함하는 다성분 결정질 시스템 |
| CN105324375A (zh) | 2013-04-24 | 2016-02-10 | 雷迪博士实验室有限公司 | 盐酸尼洛替尼的多晶型形式 |
| RU2551359C9 (ru) * | 2013-11-28 | 2021-08-20 | Общество с ограниченной ответственностью "Мамонт Фарм" | Наноразмерная слабо закристаллизованная модификация 4-метил-N-[3-(4-метилимидазол-1-ил)-5-(трифторметил)фенил]-3-[(4-пиридин-3-илпиримидин-2-ил)амино]бензамида гидрохлорида моногидрата, способ ее получения и фармацевтическая композиция на ее основе |
| WO2015092624A1 (en) | 2013-12-16 | 2015-06-25 | Ranbaxy Laboratories Limited | Nilotinib mono-oxalate and its crystalline form |
| EP3177610A4 (en) | 2014-08-08 | 2018-01-10 | Dr. Reddy's Laboratories Ltd. | Process for the preparation of polymorphic forms of nilotinib |
| CA2964198C (en) | 2014-10-16 | 2023-03-14 | Apotex Inc. | Solid forms of nilotinib hydrochloride |
| EP3404025B1 (en) * | 2017-05-16 | 2019-12-04 | F.I.S.- Fabbrica Italiana Sintetici S.p.A. | Process for the preparation of pure nilotinib and its salt |
| US12065426B2 (en) * | 2018-11-05 | 2024-08-20 | Laurus Labs Limited | Crystalline form of nilotinib hydrochloride, process for its preparation and pharmaceutical composition containing the same |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0215676D0 (en) | 2002-07-05 | 2002-08-14 | Novartis Ag | Organic compounds |
| GT200600316A (es) | 2005-07-20 | 2007-04-02 | Sales de 4-metilo-n-(3-(4-metilo-imidazol-1-ilo)-5-trifluorometilo-fenilo)-3-(4-piridina-3-ilo-pirimidina-2-iloamino)- benzamida. | |
| GT200600315A (es) * | 2005-07-20 | 2007-03-19 | Formas cristalinas de 4-metilo-n-[3-(4-metilo-imidazol-1-ilo)-5-trifluorometilo-fenilo]-3-(4-pyridina-3-ilo-pirimidina-2-iloamino)-benzamida | |
| HRP20120793T1 (hr) * | 2008-11-05 | 2012-12-31 | Teva Pharmaceutical Industries Ltd. | Kristalni oblici nilotinib hci |
-
2011
- 2011-02-25 IN IN35KO2010 patent/IN2010KO00035A/en unknown
- 2011-02-25 WO PCT/IB2011/050822 patent/WO2011086541A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2011086541A1 (en) | 2011-07-21 |